ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0135712240673827 0.32366109
NSC 101003 Null 0.0135712240673828 0.55219308
NSC 11241 C.I. Basic Red 6 0.0135712240673828 0.18915023
NSC 140377 Arnebin 1 0.0135712240673828 0.24454679
NSC 191924 Null 0.0135712240673828 0.36815908
NSC 320846 Batracylin, Daniquidone 0.0145667015252499 0.39265593
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0145667015252499 0.45201154
NSC 400938 Null 0.0145667015252499 0.15424288
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.0145667015252499 0.51727566
NSC 628000 Null 0.0145667015252499 0.19306527
Total:151  Current:65    [First] [Prev] [Next] [Last]